Breast Milk

3

Review clinical trials related to Breast Milk. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Breast-milk Enema Administration to Stimulate Passage of Meconium

Lack of passage of meconium in preterm infants delays feeding advancement and may represent a risk factor for necrotizing enterocolitis (NEC) and spontaneous intestinal perforation (SIP). Usual management of meconium impaction has included glycerin suppositories and normal saline enemas. Various methods are used in routine neonatal care to promote meconium evacuation; however, there is no consensus on the agents used and the frequency of applications

Participants needed: 20
Trial details
Phase: Phase 1Age: 23-28Biological sex: AllType: InterventionalSponsor: Wake Forest University Health SciencesUpdated: Jun 30, 2026Locations: 1
Eligibility criteria

Preterm infants born at >23 and <28 weeks' gestational age born at Atrium Health... [+3]

Infants with Necrotizing Enterocolitis (NEC) ≥ stage II [+5]

Status: Recruiting

The Effect of PIOMI and Chronobiological Nutrition on Readiness for Feeding, Full Transition to Oral Feeding and Body Weight

This is a randomized controlled experimental study evaluating the effects of oral motor intervention and chronobiological approach to feeding model applied to preterm infants on feeding readiness, transition to total oral feeding and body weight.

Participants needed: 54
Trial details
Age: 29-33Biological sex: AllType: InterventionalSponsor: Aydin Adnan Menderes UniversityUpdated: Jan 6, 2026Locations: 1
Eligibility criteria

Preterm infants with a postnatal age of 29-33 weeks, [+2]

Infants with major congenital anomalies (such as congenital heart disease, cleft... [+11]

Status: Not yet recruiting

Impact of Breast Milk miRNAs on the Infant Gut Microbiota

The first 1000 days of life are a critical period for future health. A healthy gut microbiota (GM) is essential for preventing both short-term and long-term health issues. Breast milk (BM) plays a key role in establishing the GM, as, unlike formula milk, it contains miRNAs that may interact with and modulate the microbiota. Primary Objective: To study the effect of BM on the composition of fecal miRNAs in exclusively breastfed infants compared to those fed with formula milk at different times (D10, D30, D60, M6, M12). Secondary Objectives: Analyze the effect of BM miRNAs on infant fecal microbiota, taking environmental confounding factors into account. Study the influence of BM microbiota on miRNA profiles in the milk. Examine the effect of BM microbiota on the infants' gut microbiota. Explore the links between BM miRNAs, infant gut microbiota, and intestinal inflammation.

Participants needed: 200
Trial details
Age: 18-50Biological sex: FemaleType: ObservationalSponsor: Assistance Publique - Hôpitaux de ParisUpdated: Oct 21, 2024Locations: 1
Eligibility criteria

Pregnant women in the 3rd trimester of pregnancy (3T) with a normal course of pr... [+8]

Cesarean delivery [+6]